Skip to main content

Legend Capital — Portfolio, Page 6

Investor actively backing innovative startups and growth-stage companies across various industries and funding rounds.

214
Companies
$6.2B
Total invested
$41.0M
Avg. check
47
Industries
Biotechnology 9Health Care 7Artificial Intelligence (AI) 4Life Science 3Therapeutics 3Fashion 2+41 more
Founder contacts

Verified emails & LinkedIn for founders across this portfolio.

jane@on●●●●●●●.com
linkedin.com/in/●●●●●●
Verified contacts, updated monthly
Get instant access →

Portfolio companies

Showing 121144 of 214
ZHIYI TECH
April 2022

Zhiyi Tech offers artificial intelligence technology services in the apparel industry.

Apparel · Xiaoshan$100.0M Series B
Jifan Biotechnology
April 2022

Jifan Biotechnology is a biotechnology firm that provides molecular biology reagents, diagnostic raw materials, and kits for research.

Biopharma · ChangpingSeries C
Zongmu
March 2022

Zongmu Technology is a Chinese self-driving tech firm.

Automotive · Shanghai$156.9M Series E
Tichuang Biotechnology
March 2022

Tichuang Biotechnology is an enterprise that realizes the industrialization and commercialization of cross-material types.

Biotechnology · Guangzhou$100.0M Series A
Medilink Therapeutics
March 2022

Medilink Therapeutics is a biotech company focusing on next-generation antibody-drug conjugate Research & development.

Biotechnology · Suzhou$70.0M Series B
Jianshu
January 2022

Jianshu is a website and mobile application that allows users to read and write Chinese and English versions of books.

EBooks · ShanghaiSeries Unknown
Tanma SCRM
January 2022

Tanma SCRM is a full-process private domain traffic solution provider that helps customers improve their private domain traffic operations.

CRM · Haidian$10.0M Series B
Xbiome
December 2021

Xbiome is a developer of microbial pharmaceuticals designed to treat microecological intestinal disorders.

Artificial Intelligence (AI) · Shenzhen$100.0M Series B
ColorTech Bio
December 2021

ColorTech Bio researches and develops precision molecular diagnostic equipment.

Biotechnology · Suzhou$23.5M Series B
Inossem
December 2021

Inossem specializes in R&D and consulting services for enterprise applications.

Artificial Intelligence (AI) · NanjingSeries C
Paixue Che
November 2021

Paixue Che is a internet learning service company providing the construction of a one-stop learning car service.

Automotive · ShanghaiSeries C
Wangdiantong
October 2021

Wangdiantong is an E-commerce ERP management system that provides smart retail solutions for retailers digital transformation.

E-Commerce · Beijing$312.0M Series D
Sciwind Biosciences
October 2021

Sciwind Biosciences is a drug research and development company for metabolic diseases.

Biotechnology · Hangzhou$69.8M Series C
Fiture
September 2021

Fiture is a smart household fitness equipment brand.

Artificial Intelligence (AI) · Chengdu$1.3M Secondary Market
Liangyihui
July 2021

Liangyihui is an online medicine and therapeutic information service platform in oncology.

Health Care · Shanghai$55.9M Series C
Bangsun Technology
July 2021

Real-time financial risk management company based in Hangzhou.

Financial Services · HangzhouSeries Unknown
YEASEN Biotechnology
June 2021

YEASEN commitment to developing and producing enzyme products.

Biotechnology · Shanghai$38.8M Series B
RecBio
June 2021

Focusing on major innovative vaccines with independent intellectual property rights.

Health Care · Taizhou$156.3M Series C
Feiyu
June 2021

Feiyu is an online purchasing platform for luxury trading bags.

E-Commerce · Jiading$30.0M Series B
GensKey
June 2021

GensKey is a genetic testing medical diagnostic service provider

Health Care · Beijing$15.7M Series C
Bloks Technology Group
May 2021

Bloks Group uses innovative technology to create the ultimate product experience and create long-term value for users.

Animation · Minhang$93.2M Series B
Shanghai Cell Therapy Group
March 2021

Shanghai Cell Therapy Group is a provider of cellular diagnosis center combining cellular research and treatment services.

Biotechnology · Jiading$76.6M Series D
Exegenesis Bio
February 2021

Exegenesis Bio is a Gene therapy start-up.

Biotechnology · LansdaleSeries B
Hongshan Information Technology
January 2021

Hongshan Information Technology is a 5G and future ICT developers

Communications Infrastructure · BeijingSeries Unknown

Where Legend Capital invests

Biotechnology9
Health Care7
Artificial Intelligence (AI)4
Life Science3
Therapeutics3
Fashion2

About Legend Capital's portfolio

How many companies has Legend Capital invested in?

Legend Capital has invested in 214 companies tracked in our database. The portfolio spans multiple industries and funding stages, from seed-stage startups to late-stage companies.

What industries does Legend Capital invest in?

Legend Capital's top investment sectors include Biotechnology, Health Care, Artificial Intelligence (AI), Life Science, Therapeutics. The firm invests across 47 different industry categories.

What is Legend Capital's largest investment?

Among tracked funding rounds, Wangdiantong received $312.0M in a Series D round. Legend Capital's total known invested capital is $6.2B.

What is the average investment size for Legend Capital?

Legend Capital's average investment size is $41.0M across its portfolio of 214 companies.

What are Legend Capital's most recent investments?

Recent Legend Capital portfolio additions include ZHIYI TECH, Jifan Biotechnology, Zongmu, Tichuang Biotechnology, Medilink Therapeutics. These companies were founded in 2020 or later.

Reach the founders behind these 214 companies
Verified emails and LinkedIn profiles, updated monthly.
Get instant access →